Massachusetts Medicaid

Does Massachusetts Medicaid cover Mounjaro?

Find your Medicaid card name in Massachusetts

Quick answer · Type 2 Diabetes

Massachusetts Medicaid covers Mounjaro for type 2 diabetes with prior authorization on Medicaid.

  • Medicaid: Covered (preferred drug). Lab results confirming eligibility

Last verified June 4, 2026. Source: policy-348.html. How we verify this data →

Check your card for your exact plan →

Mounjaro for Type 2 Diabetes

What Massachusetts Medicaid requires, by plan type. Open this indication on its own page →

Medicaid

Covered (preferred drug)

What you need to qualify

  • Lab results confirming eligibility

Qualification pathways

You can qualify through any one of these.

Initial approval for type 2 diabetes

All of:

  • Appropriate diagnosis of type 2 diabetes
  • Baseline A1C dated within 90 days prior to initiation
  • Requested agent will not be used in combination with another GLP-1 receptor agonist
  • If requested quantity exceeds quantity limits, clinical rationale provided

SmartPA for type 2 diabetes (no PA request needed)

All of:

  • Claims within quantity limit
  • Member has history of medical claims for type 2 diabetes mellitus OR history of medical claims for prediabetes with history of paid claims for at least 84 days of GLP-1/GIP/GLP-1 agonist therapy within the last 120-day period

Documentation to bring

  • Appropriate diagnosis of type 2 diabetes
  • Baseline A1C lab result dated within 90 days prior to initiation
  • Attestation that requested agent will not be used in combination with another GLP-1 receptor agonist
  • If quantity exceeds limits: clinical rationale why dose cannot be consolidated or for exceeding FDA-approved dosing
  • For recertification: current A1C dated within last 90 days
  • For recertification: evidence of A1C reduction, A1C ≤ 7%, or treatment plan for A1C escalation

Quantity limits

  • all strengths — 1 carton of 4 prefilled pens per 28-day supply

Approval and renewal

  • To renew, the plan looks for improvement in A1C and Current A1C within last 90 days required. Must show: reduction in A1C since initiation, OR A1C ≤ 7% (dated within last 90 days), OR treatment plan addressing escalation of therapy for A1C reduction.

Not covered when

  • Combination use with another GLP-1 receptor agonist is prohibited unless transitioning (with discontinuation of prior GLP-1)

Policy note: Mounjaro is a Preferred Drug (PD) in the MassHealth formulary for type 2 diabetes (listed as GIP/GLP-1 Agonist). No step therapy through lower-potency GLP-1s is required for initial T2DM approval. Mounjaro 15 mg (maximum dose) is itself a step-therapy prerequisite for other agents (e.g., Bydureon Bcise, Rybelsus, Soliqua, Xultophy) requiring prior failure of 'high-potency GLP-1s'. Prediabetes indication also covered under same section with metformin step-therapy requirements. SmartPA pathway applies.

verified June 4, 2026 · source: policy-348.html

Why Mounjaro requests get denied by Massachusetts Medicaid

Based on what this policy asks for. Fix these before the first submission.

  1. Wrong brand for the diagnosis. Mounjaro and Zepbound are the same molecule with different approved uses; a request for Mounjaro under a diagnosis that matches Zepbound is routinely denied.

Frequently asked questions

Does Massachusetts Medicaid cover Mounjaro?
Massachusetts Medicaid covers Mounjaro for type 2 diabetes with prior authorization on Medicaid.
What does Massachusetts Medicaid require to renew Mounjaro?
Improvement in A1C and Current A1C within last 90 days required. Must show: reduction in A1C since initiation, OR A1C ≤ 7% (dated within last 90 days), OR treatment plan addressing escalation of therapy for A1C reduction.
How current is this information?
This page reflects Massachusetts Medicaid's written policy as of its current version, last verified against the source document on June 4, 2026.

Other medications under Massachusetts Medicaid

Mounjaro coverage under other plans

All insurance plans · All medications

This page summarizes Massachusetts Medicaid's written prior-authorization policy. It is not a guarantee of coverage; plans vary by employer and benefit design. Verify with your plan before relying on it.